What a Certificate of Analysis Can—and Cannot—Tell You

A certificate of analysis (CoA) is a quality document associated with a specific material, usually a specific production lot. It reports selected test results against stated specifications. For peptide research, that can make a CoA a useful starting point for judging documentation quality—but it is not the same as independent verification, a complete quality dossier, or proof that a material is suitable for a particular experiment.

The central question is not simply, “Does this peptide have a CoA?” It is, “What claims does this CoA actually support, and how strong is the evidence behind each claim?”

A credible CoA should clearly connect the document to the material being evaluated. Look for:

The lot number is especially important. A generic, undated certificate may describe a product family or a historical batch rather than the vial or container under review. The lot printed on the container should match the lot on the CoA exactly. If it does not, the document provides weak evidence for that particular material.

Identity testing also needs context. Techniques such as mass spectrometry can support a measured molecular mass consistent with the intended peptide. However, a matching mass alone may not distinguish every possible sequence, isomer, truncation pattern, or closely related impurity. A careful reader should ask what method was used, what result was observed, and whether the method can resolve the identity question being asked.

Peptide CoAs often present a high purity percentage. That number is meaningful only alongside the analytical method and calculation basis. Common approaches include chromatographic methods such as reverse-phase high-performance liquid chromatography (RP-HPLC), but laboratories may use different columns, mobile phases, detection wavelengths, integration rules, and reference materials.

As a result, two laboratories can report different purity values for comparable material without either result being automatically fraudulent. More importantly, a reported chromatographic purity is not necessarily the percentage of all chemical content in the container. It may exclude water, residual solvents, counterions, salts, truncated sequences, or compounds that the method does not detect effectively.

Useful questions include:

A single headline percentage should therefore be interpreted as one measurement under defined conditions—not as a universal description of the material.

Other CoA fields may be more informative than a bold purity value. For example, a molecular-mass result can be compared with the expected mass, while appearance, water content, residual solvent, counterion content, or salt form may affect how researchers interpret a sample.

A CoA may also report endotoxin, bioburden, or sterility-related testing. These terms are not interchangeable. A low endotoxin result does not establish sterility, and a “sterile” label does not explain the validation, sampling plan, packaging process, or storage history behind that claim. If microbiological status matters to a study, the relevant test, limit, sample, and method should be visible rather than implied.

For research materials, “research use only” language is another important boundary. It signals that the documentation is not a substitute for the broader controls required for clinical, diagnostic, or other regulated applications.

Professional formatting can improve readability, but appearance is not evidence of analytical quality. Consider whether the CoA identifies the testing laboratory and whether the laboratory describes relevant quality systems or accreditation. Accreditation, where applicable, can provide useful information about competence for specified methods, but it does not mean every analyte, test, or result is automatically validated.

The strongest documentation usually makes the chain of evidence visible: who tested the sample, which method was used, when it was tested, what acceptance criteria applied, and who reviewed the result. A document that lists only “pass” outcomes without numerical results or methods is harder to independently evaluate.

External testing can add confidence, but it also has limitations. A third-party report may test a retained sample rather than the exact container received, or it may use a different method from the original release test. Those differences should be documented rather than silently treated as confirmation of every claim.

Several mistakes recur when researchers review peptide documentation:

Before relying on a CoA in a research record, confirm that:

A CoA is best used as one part of a documentation package that may also include a product specification, safety data sheet, storage record, method information, and independent testing when the research question warrants it. Its value comes from the transparency and relevance of the evidence—not from the certificate format alone.

Educational disclaimer: This article is for research-literacy and documentation-evaluation purposes. It is not a protocol, product endorsement, or substitute for institutional quality, safety, regulatory, or analytical review.